Early (Day 15 Post Diagnosis) Peripheral Blood Assessment of Measurable Residual Disease in Flow Cytometry is a Strong Predictor of Outcome in Childhood B‐Lineage Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Early (Day 15 Post Diagnosis) Peripheral Blood Assessment of Measurable Residual Disease in Flow Cytometry is a Strong Predictor of Outcome in Childhood B‐Lineage Lymphoblastic Leukemia

Published:2019-02-07 Issue:2 Volume:96 Page:128-133
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Loosveld Marie¹²,Nivaggioni Vanessa¹,Arnoux Isabelle¹,Bernot Denis¹,Michel Gérard³,Béné Marie C.⁴⁵^ORCID,Eveillard Marion⁴⁵⁶

Affiliation:

1. APHM, Laboratoire d'HématologieHôpital La Timone Marseille France

2. CNRS, INSERM, CIMLAix Marseille University Marseille France

3. APHM, Service d'Hématologie et d'Oncologie PédiatriqueHôpital La Timone Marseille France

4. Service d'Hématologie BiologiqueCHU Nantes Nantes France

5. CIRCNA Nantes France

6. Laboratory MedecineMemorial Sloan Kettering Cancer Center New York New York

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21769

Reference33 articles.

1. Acute Lymphoblastic Leukemia

2. Minimal residual disease in adult ALL: Technical aspects and implications for correct clinical interpretation. Hematology American Society of Hematology Education;Brüggemann M;Dent Prog,2017

3. Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

4. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

5. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The RAS‐signaling‐pathway‐mutation‐related prognosis in B‐cell acute lymphoblastic leukemia: A report from South China children's leukemia group;Hematological Oncology;2024-04-02

2. Issue Highlights—September 2022;Cytometry Part B: Clinical Cytometry;2022-09

3. Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR;The Journal of Molecular Diagnostics;2022-06

4. Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed Therapy;Blood Cancer Discovery;2021-04-10

5. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol;BMC Cancer;2021-01-13